View in EDS

Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis.

Saved in:
Bibliographic Details
Title: Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis.
Authors: Colloca GA; Oncologia Medica & Innovation, Via Aicardi N. 37, 18100, Imperia, Italy.; UOSD Oncologia Territoriale, AUSL di Bologna, Sasso Marconi, Bologna, Italy., Venturino A; Oncologia Medica & Innovation, Via Aicardi N. 37, 18100, Imperia, Italy. vent.ant.470@gmail.com.
Source: Investigational new drugs [Invest New Drugs] 2026 Mar 07. Date of Electronic Publication: 2026 Mar 07.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41793630
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAF<superscript>V600E</superscript> colorectal cancer: a study cohort-level analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Colloca+GA%22">Colloca GA</searchLink>; Oncologia Medica & Innovation, Via Aicardi N. 37, 18100, Imperia, Italy.; UOSD Oncologia Territoriale, AUSL di Bologna, Sasso Marconi, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Venturino+A%22">Venturino A</searchLink>; Oncologia Medica & Innovation, Via Aicardi N. 37, 18100, Imperia, Italy. vent.ant.470@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309330%22">Investigational new drugs</searchLink> [Invest New Drugs] 2026 Mar 07. <i>Date of Electronic Publication: </i>2026 Mar 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309330 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-0646 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676997%22">01676997 </searchLink><i>NLM ISO Abbreviation: </i>Invest New Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41793630
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10637-026-01607-1
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Prognostic factors and outcome measures after BRAF-directed targeted therapy of unresectable metastatic BRAFV600E colorectal cancer: a study cohort-level analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Colloca GA
      – PersonEntity:
          Name:
            NameFull: Venturino A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 03
              Text: 2026 Mar 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1573-0646
          Titles:
            – TitleFull: Investigational new drugs
              Type: main
ResultId 1